AXP
73
-5
AAL
35
-3
L
49
-5
FTI
82
-7
SNA
53
-5
M
40
-2
NOV
45
-4
SRCL
34
-2
LLY
67
10
XYL
52
-8
OI
60
10
DOW
44
-7
AAPL
61
-4
WBA
22
-5
UNM
66
-2
SLG
55
-7
AFL
57
-5
ADM
28
-8
JWN
60
-5
WMB
62
-8
AXP
73
-5
AAL
35
-3
L
49
-5
FTI
82
-7
SNA
53
-5
M
40
-2
NOV
45
-4
SRCL
34
-2
LLY
67
10
XYL
52
-8
OI
60
10
DOW
44
-7
AAPL
61
-4
WBA
22
-5
UNM
66
-2
SLG
55
-7
AFL
57
-5
ADM
28
-8
JWN
60
-5
WMB
62
-8
Financhill
Back

Immunovant Stock Predictions

The little-known AI stock you need to read about now...

Get the name - FREE.
Sell
28

IMVT
Immunovant

Last Price:
28.50
Seasonality Move:
10.77%

7 Day Trial

ALL ACCESS PASS

$ 7

America's Final Republican President

Click here to see his 2024 election prediction.

Immunovant Stock Forecast

  • Over the next 52 weeks, Immunovant has on average historically risen by 57% based on the past 4 years of stock performance.
  • Immunovant has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Immunovant Stock Undervalued?
    The current Immunovant [IMVT] share price is $28.52. The Score for IMVT is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • IMVT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Immunovant Stock Go Up Next Year?

  • Over the next 52 weeks, Immunovant has on average historically risen by 57% based on the past 4 years of stock performance.

Immunovant Stock Rating

Sell
28
Immunovant (IMVT) is a Sell

Is Immunovant overpriced?

  • Immunovant has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Immunovant Stock Price History

Is IMVT stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IMVT is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
immunovant.com

52-Week Data

52-Week High:
45.58
52-Week Low:
17.53

Prediction Charts

Market Cap:
4.14B
Price in USD:
28.52
Volume:
1.28M
Beta:
0.75

Technical Analysis

SMA50:
31.63
SMA100:
35.68
SMA200:
32.24
52-Wk Change:
61.86%

Stock Predictions

  • Is Immunovant stock public?
    Yes, Immunovant is a publicly traded company.
  • What is the Immunovant stock quote today?
    The Immunovant stock price is 28.52 USD today.
  • How to buy Immunovant stock online?
    You can buy Immunovant shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-12 30.50 29.38 30.52 28.79
Apr-15 29.51 30.49 30.61 29.28
Apr-16 30.34 30.42 30.96 29.72
Apr-17 30.20 28.43 30.35 28.23
Apr-18 28.21 28.33 29.22 27.99
Apr-19 28.27 28.22 28.64 27.33
Apr-22 28.59 28.75 28.89 27.92
Apr-23 28.94 28.61 29.86 28.54
Apr-24 28.72 28.80 29.54 28.40
Apr-25 28.21 27.75 28.52 27.44
Apr-26 27.80 27.17 27.97 26.97
Apr-29 27.32 27.49 27.81 26.93
Apr-30 27.17 27.47 28.57 26.83
May-1 27.31 28.52 29.26 27.30

Immunovant Earnings

Immunovant Earnings Report: Per Share Immunovant Earnings Q1 Q2 Q3 and Q4 last year and next year.

Immunovant Forecast Revenue Growth

Immunovant Stock Analysis: Historical quarterly revenues per share for Immunovant and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.16 per share, and a decrease next year of $0.09 per share.

* Immunovant stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.